container_end_page 384
container_issue 2
container_start_page 383
container_title American journal of kidney diseases
container_volume 44
creator Yokoyama, Keitaro
Katoh, Naohiko
Kubo, Hitoshi
Murai, Seizo
Imamura, Noritugu
Shoji, Ryo
Yamamoto, Hiroyasu
Shigematsu, Takashi
Nakayama, Masaaki
Takasu, Shinji
Kono, Takashi
Yoshida, Toyohiko
Hosoya, Tatsuo
description
doi_str_mv 10.1053/j.ajkd.2004.05.038
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66720170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638604008303</els_id><sourcerecordid>66720170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-3a0553a4f6e3e9427538e8a10bc32b39429e30228d85e0655ac585e898c7916f3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-AQ-yJ2-Jk93sZgO9SP2qFoqg52WzmdStaVKzieC_d0sL3jzNMDzvC_MQcplAnIDgN-vYrD_LmAGkMYgYuDoi40QwHknF1TEZA8tYJLmSI3Lm_RoAci7lKRkFSKYhNybTWe0aZ01NvVs1rgprY5G2Fe0_kL7c3C1f57RoG6SrwZUYYPTUNfTZbE1zTk4qU3u8OMwJeX-4f5s9RYvl43x2u4hsKtM-4gaE4CatJHLMU5YJrlCZBArLWcHDJUcOjKlSCQQphLEibCpXNssTWfEJud73brv2a0Df643zFuvaNNgOXkuZMUgyCCDbg7Zrve-w0tvObUz3oxPQO2d6rXfO9M6ZBqGDsxC6OrQPxQbLv8hBUgCmewDDj98OO-2tw6CpdB3aXpet-6__FysOej4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66720170</pqid></control><display><type>article</type><title>Clinical significance of the K/DOQI bone guidelines in Japan</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yokoyama, Keitaro ; Katoh, Naohiko ; Kubo, Hitoshi ; Murai, Seizo ; Imamura, Noritugu ; Shoji, Ryo ; Yamamoto, Hiroyasu ; Shigematsu, Takashi ; Nakayama, Masaaki ; Takasu, Shinji ; Kono, Takashi ; Yoshida, Toyohiko ; Hosoya, Tatsuo</creator><creatorcontrib>Yokoyama, Keitaro ; Katoh, Naohiko ; Kubo, Hitoshi ; Murai, Seizo ; Imamura, Noritugu ; Shoji, Ryo ; Yamamoto, Hiroyasu ; Shigematsu, Takashi ; Nakayama, Masaaki ; Takasu, Shinji ; Kono, Takashi ; Yoshida, Toyohiko ; Hosoya, Tatsuo</creatorcontrib><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2004.05.038</identifier><identifier>PMID: 15264200</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Blood Specimen Collection ; Bone Diseases, Metabolic - blood ; Bone Diseases, Metabolic - etiology ; Bone Diseases, Metabolic - prevention &amp; control ; Humans ; Hyperparathyroidism, Secondary - blood ; Hyperparathyroidism, Secondary - etiology ; Japan ; Kidney Diseases - complications ; Kidney Diseases - metabolism ; Kidney Diseases - therapy ; Parathyroid Hormone - blood ; Phosphorus - blood ; Practice Guidelines as Topic ; Reference Values ; Time Factors ; United States ; Vitamin D - administration &amp; dosage ; Vitamin D - therapeutic use</subject><ispartof>American journal of kidney diseases, 2004-08, Vol.44 (2), p.383-384</ispartof><rights>2004 National Kidney Foundation, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-3a0553a4f6e3e9427538e8a10bc32b39429e30228d85e0655ac585e898c7916f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0272638604008303$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15264200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yokoyama, Keitaro</creatorcontrib><creatorcontrib>Katoh, Naohiko</creatorcontrib><creatorcontrib>Kubo, Hitoshi</creatorcontrib><creatorcontrib>Murai, Seizo</creatorcontrib><creatorcontrib>Imamura, Noritugu</creatorcontrib><creatorcontrib>Shoji, Ryo</creatorcontrib><creatorcontrib>Yamamoto, Hiroyasu</creatorcontrib><creatorcontrib>Shigematsu, Takashi</creatorcontrib><creatorcontrib>Nakayama, Masaaki</creatorcontrib><creatorcontrib>Takasu, Shinji</creatorcontrib><creatorcontrib>Kono, Takashi</creatorcontrib><creatorcontrib>Yoshida, Toyohiko</creatorcontrib><creatorcontrib>Hosoya, Tatsuo</creatorcontrib><title>Clinical significance of the K/DOQI bone guidelines in Japan</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><subject>Blood Specimen Collection</subject><subject>Bone Diseases, Metabolic - blood</subject><subject>Bone Diseases, Metabolic - etiology</subject><subject>Bone Diseases, Metabolic - prevention &amp; control</subject><subject>Humans</subject><subject>Hyperparathyroidism, Secondary - blood</subject><subject>Hyperparathyroidism, Secondary - etiology</subject><subject>Japan</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - metabolism</subject><subject>Kidney Diseases - therapy</subject><subject>Parathyroid Hormone - blood</subject><subject>Phosphorus - blood</subject><subject>Practice Guidelines as Topic</subject><subject>Reference Values</subject><subject>Time Factors</subject><subject>United States</subject><subject>Vitamin D - administration &amp; dosage</subject><subject>Vitamin D - therapeutic use</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK3-AQ-yJ2-Jk93sZgO9SP2qFoqg52WzmdStaVKzieC_d0sL3jzNMDzvC_MQcplAnIDgN-vYrD_LmAGkMYgYuDoi40QwHknF1TEZA8tYJLmSI3Lm_RoAci7lKRkFSKYhNybTWe0aZ01NvVs1rgprY5G2Fe0_kL7c3C1f57RoG6SrwZUYYPTUNfTZbE1zTk4qU3u8OMwJeX-4f5s9RYvl43x2u4hsKtM-4gaE4CatJHLMU5YJrlCZBArLWcHDJUcOjKlSCQQphLEibCpXNssTWfEJud73brv2a0Df643zFuvaNNgOXkuZMUgyCCDbg7Zrve-w0tvObUz3oxPQO2d6rXfO9M6ZBqGDsxC6OrQPxQbLv8hBUgCmewDDj98OO-2tw6CpdB3aXpet-6__FysOej4</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Yokoyama, Keitaro</creator><creator>Katoh, Naohiko</creator><creator>Kubo, Hitoshi</creator><creator>Murai, Seizo</creator><creator>Imamura, Noritugu</creator><creator>Shoji, Ryo</creator><creator>Yamamoto, Hiroyasu</creator><creator>Shigematsu, Takashi</creator><creator>Nakayama, Masaaki</creator><creator>Takasu, Shinji</creator><creator>Kono, Takashi</creator><creator>Yoshida, Toyohiko</creator><creator>Hosoya, Tatsuo</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Clinical significance of the K/DOQI bone guidelines in Japan</title><author>Yokoyama, Keitaro ; Katoh, Naohiko ; Kubo, Hitoshi ; Murai, Seizo ; Imamura, Noritugu ; Shoji, Ryo ; Yamamoto, Hiroyasu ; Shigematsu, Takashi ; Nakayama, Masaaki ; Takasu, Shinji ; Kono, Takashi ; Yoshida, Toyohiko ; Hosoya, Tatsuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-3a0553a4f6e3e9427538e8a10bc32b39429e30228d85e0655ac585e898c7916f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Blood Specimen Collection</topic><topic>Bone Diseases, Metabolic - blood</topic><topic>Bone Diseases, Metabolic - etiology</topic><topic>Bone Diseases, Metabolic - prevention &amp; control</topic><topic>Humans</topic><topic>Hyperparathyroidism, Secondary - blood</topic><topic>Hyperparathyroidism, Secondary - etiology</topic><topic>Japan</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - metabolism</topic><topic>Kidney Diseases - therapy</topic><topic>Parathyroid Hormone - blood</topic><topic>Phosphorus - blood</topic><topic>Practice Guidelines as Topic</topic><topic>Reference Values</topic><topic>Time Factors</topic><topic>United States</topic><topic>Vitamin D - administration &amp; dosage</topic><topic>Vitamin D - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yokoyama, Keitaro</creatorcontrib><creatorcontrib>Katoh, Naohiko</creatorcontrib><creatorcontrib>Kubo, Hitoshi</creatorcontrib><creatorcontrib>Murai, Seizo</creatorcontrib><creatorcontrib>Imamura, Noritugu</creatorcontrib><creatorcontrib>Shoji, Ryo</creatorcontrib><creatorcontrib>Yamamoto, Hiroyasu</creatorcontrib><creatorcontrib>Shigematsu, Takashi</creatorcontrib><creatorcontrib>Nakayama, Masaaki</creatorcontrib><creatorcontrib>Takasu, Shinji</creatorcontrib><creatorcontrib>Kono, Takashi</creatorcontrib><creatorcontrib>Yoshida, Toyohiko</creatorcontrib><creatorcontrib>Hosoya, Tatsuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yokoyama, Keitaro</au><au>Katoh, Naohiko</au><au>Kubo, Hitoshi</au><au>Murai, Seizo</au><au>Imamura, Noritugu</au><au>Shoji, Ryo</au><au>Yamamoto, Hiroyasu</au><au>Shigematsu, Takashi</au><au>Nakayama, Masaaki</au><au>Takasu, Shinji</au><au>Kono, Takashi</au><au>Yoshida, Toyohiko</au><au>Hosoya, Tatsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of the K/DOQI bone guidelines in Japan</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>44</volume><issue>2</issue><spage>383</spage><epage>384</epage><pages>383-384</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15264200</pmid><doi>10.1053/j.ajkd.2004.05.038</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2004-08, Vol.44 (2), p.383-384
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_66720170
source MEDLINE; Elsevier ScienceDirect Journals
subjects Blood Specimen Collection
Bone Diseases, Metabolic - blood
Bone Diseases, Metabolic - etiology
Bone Diseases, Metabolic - prevention & control
Humans
Hyperparathyroidism, Secondary - blood
Hyperparathyroidism, Secondary - etiology
Japan
Kidney Diseases - complications
Kidney Diseases - metabolism
Kidney Diseases - therapy
Parathyroid Hormone - blood
Phosphorus - blood
Practice Guidelines as Topic
Reference Values
Time Factors
United States
Vitamin D - administration & dosage
Vitamin D - therapeutic use
title Clinical significance of the K/DOQI bone guidelines in Japan
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T09%3A17%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20the%20K/DOQI%20bone%20guidelines%20in%20Japan&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Yokoyama,%20Keitaro&rft.date=2004-08-01&rft.volume=44&rft.issue=2&rft.spage=383&rft.epage=384&rft.pages=383-384&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2004.05.038&rft_dat=%3Cproquest_cross%3E66720170%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66720170&rft_id=info:pmid/15264200&rft_els_id=S0272638604008303&rfr_iscdi=true